{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:47:08Z","timestamp":1786981628049,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fellowship Program Grant \u00b43E\u00b4, the Exchange in Endocrinology Expertise, Board of Endocrinology of the UEMS and Novo Nordisk A\/S and Novartis"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11102-020-01112-5","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:13:49Z","timestamp":1606169629000},"page":"334-350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Pre-operative serum inflammation-based scores in patients with pituitary adenomas"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4959-5725","authenticated-orcid":false,"given":"Pedro","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3660-6093","authenticated-orcid":false,"given":"Friso","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-7580","authenticated-orcid":false,"given":"Olaf M.","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5208-921X","authenticated-orcid":false,"given":"Wouter R.","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-9432","authenticated-orcid":false,"given":"M\u00e1rta","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5817-3594","authenticated-orcid":false,"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-9866","authenticated-orcid":false,"given":"Alberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"issue":"2","key":"1112_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ecl.2017.01.004","volume":"46","author":"P Marques","year":"2017","unstructured":"Marques P, Korbonits M (2017) Genetic aspects of pituitary adenomas. Endocrinol Metab Clin N Am 46(2):335\u2013374. https:\/\/doi.org\/10.1016\/j.ecl.2017.01.004","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"1112_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000371806","volume":"101","author":"E Chatzellis","year":"2015","unstructured":"Chatzellis E, Alexandraki KI, Androulakis II, Kaltsas G (2015) Aggressive pituitary tumors. Neuroendocrinology 101(2):87\u2013104. https:\/\/doi.org\/10.1159\/000371806","journal-title":"Neuroendocrinology"},{"key":"1112_CR3","doi-asserted-by":"crossref","unstructured":"Trouillas, J., Roy, P., Sturm, N., Dantony, E., Cortet-Rudelli, C., Viennet, G., Bonneville, J.F., Assaker, R., Auger, C., Brue, T., Cornelius, A., Dufour, H., Jouanneau, E., Francois, P., Galland, F., Mougel, F., Chapuis, F., Villeneuve, L., Maurage, C.A., Figarella-Branger, D., Raverot, G., members of, H., Barlier, A., Bernier, M., Bonnet, F., Borson-Chazot, F., Brassier, G., Caulet-Maugendre, S., Chabre, O., Chanson, P., Cottier, J.F., Delemer, B., Delgrange, E., Di Tommaso, L., Eimer, S., Gaillard, S., Jan, M., Girard, J.J., Lapras, V., Loiseau, H., Passagia, J.G., Patey, M., Penfornis, A., Poirier, J.Y., Perrin, G., Tabarin, A.: A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126(1), 123\u2013135 (2013)","DOI":"10.1007\/s00401-013-1084-y"},{"issue":"1","key":"1112_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s40478-019-0830-3","volume":"7","author":"P Marques","year":"2019","unstructured":"Marques P, Barry S, Carlsen E, Collier D, Ronaldson A, Awad S, Dorward N, Grieve J, Mendoza N, Muquit S, Grossman AB, Balkwill F, Korbonits M (2019) Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours. Acta Neuropathol Commun 7(1):172. https:\/\/doi.org\/10.1186\/s40478-019-0830-3","journal-title":"Acta Neuropathol Commun"},{"key":"1112_CR5","doi-asserted-by":"publisher","first-page":"142425","DOI":"10.1155\/2014\/142425","volume":"2014","author":"D Bugada","year":"2014","unstructured":"Bugada D, Allegri M, Lavand\u2019homme P, De Kock M, Fanelli G (2014) Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed Res Int 2014:142425. https:\/\/doi.org\/10.1155\/2014\/142425","journal-title":"Biomed Res Int"},{"issue":"1","key":"1112_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semcancer.2011.12.005","volume":"22","author":"FR Balkwill","year":"2012","unstructured":"Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22(1):33\u201340. https:\/\/doi.org\/10.1016\/j.semcancer.2011.12.005","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1112_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MCO.0b013e32832a7902","volume":"12","author":"DC McMillan","year":"2009","unstructured":"McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223\u2013226. https:\/\/doi.org\/10.1097\/MCO.0b013e32832a7902","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"1","key":"1112_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11060-018-2776-x","volume":"138","author":"M Chen","year":"2018","unstructured":"Chen M, Zheng SH, Yang M, Chen ZH, Li ST (2018) The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study. J Neurooncol 138(1):113\u2013122. https:\/\/doi.org\/10.1007\/s11060-018-2776-x","journal-title":"J Neurooncol"},{"issue":"6","key":"1112_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s11255-017-1554-6","volume":"49","author":"X Chang","year":"2017","unstructured":"Chang X, Zhang F, Liu T, Wang W, Guo H (2017) Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis. Int Urol Nephrol 49(6):967\u2013974. https:\/\/doi.org\/10.1007\/s11255-017-1554-6","journal-title":"Int Urol Nephrol"},{"issue":"22","key":"1112_CR10","doi-asserted-by":"publisher","first-page":"36857","DOI":"10.18632\/oncotarget.16143","volume":"8","author":"H Tang","year":"2017","unstructured":"Tang H, Lu W, Li B, Li C, Xu Y, Dong J (2017) Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis. Oncotarget 8(22):36857\u201336868. https:\/\/doi.org\/10.18632\/oncotarget.16143","journal-title":"Oncotarget"},{"issue":"2","key":"1112_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.amjsurg.2009.08.041","volume":"200","author":"I Bhatti","year":"2010","unstructured":"Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI (2010) Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 200(2):197\u2013203. https:\/\/doi.org\/10.1016\/j.amjsurg.2009.08.041","journal-title":"Am J Surg"},{"issue":"3","key":"1112_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JC Chan","year":"2017","unstructured":"Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, Clarke SJ (2017) The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg 265(3):539\u2013546. https:\/\/doi.org\/10.1097\/SLA.0000000000001743","journal-title":"Ann Surg"},{"issue":"6","key":"1112_CR13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/jso.24549","volume":"115","author":"T Yang","year":"2017","unstructured":"Yang T, Zhu J, Zhao L, Mai K, Ye J, Huang S, Zhao Y (2017) Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection. J Surg Oncol 115(6):718\u2013728. https:\/\/doi.org\/10.1002\/jso.24549","journal-title":"J Surg Oncol"},{"issue":"11","key":"1112_CR14","doi-asserted-by":"publisher","first-page":"e0142159","DOI":"10.1371\/journal.pone.0142159","volume":"10","author":"DG Watt","year":"2015","unstructured":"Watt DG, Proctor MJ, Park JH, Horgan PG, McMillan DC (2015) The Neutrophil-Platelet Score (NPS) predicts survival in primary operable colorectal cancer and a variety of common cancers. PLoS ONE 10(11):e0142159. https:\/\/doi.org\/10.1371\/journal.pone.0142159","journal-title":"PLoS ONE"},{"key":"1112_CR15","doi-asserted-by":"publisher","first-page":"105397","DOI":"10.1016\/j.clineuro.2019.105397","volume":"184","author":"R Liang","year":"2019","unstructured":"Liang R, Li J, Tang X, Liu Y (2019) The prognostic role of preoperative systemic immune-inflammation index and albumin\/globulin ratio in patients with newly diagnosed high-grade glioma. Clin Neurol Neurosurg 184:105397. https:\/\/doi.org\/10.1016\/j.clineuro.2019.105397","journal-title":"Clin Neurol Neurosurg"},{"issue":"5","key":"1112_CR16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S1499-3872(14)60284-8","volume":"13","author":"J Ahmad","year":"2014","unstructured":"Ahmad J, Grimes N, Farid S, Morris-Stiff G (2014) Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review. Hepatobiliary Pancreat Dis Int 13(5):474\u2013481","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"1112_CR17","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3389\/fphar.2018.00886","volume":"9","author":"PF Wang","year":"2018","unstructured":"Wang PF, Meng Z, Song HW, Yao K, Duan ZJ, Yu CJ, Li SW, Yan CX (2018) Preoperative changes in hematological markers and predictors of glioma grade and survival. Front Pharmacol 9:886. https:\/\/doi.org\/10.3389\/fphar.2018.00886","journal-title":"Front Pharmacol"},{"issue":"2","key":"1112_CR18","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.3892\/ol.2018.9870","volume":"17","author":"T Yang","year":"2019","unstructured":"Yang T, Mao P, Chen X, Niu X, Xu G, Bai X, Xie W (2019) Inflammatory biomarkers in prognostic analysis for patients with glioma and the establishment of a nomogram. Oncol Lett 17(2):2516\u20132522. https:\/\/doi.org\/10.3892\/ol.2018.9870","journal-title":"Oncol Lett"},{"key":"1112_CR19","doi-asserted-by":"publisher","first-page":"e677","DOI":"10.1016\/j.wneu.2019.03.241","volume":"127","author":"M Lin","year":"2019","unstructured":"Lin M, Hu T, Yan L, Xiao D, Zhao H, Yan P (2019) Can systemic inflammatory markers be used to predict the pathological grade of meningioma before surgery? World Neurosurg 127:e677\u2013e684. https:\/\/doi.org\/10.1016\/j.wneu.2019.03.241","journal-title":"World Neurosurg"},{"issue":"1","key":"1112_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/cts.12700","volume":"13","author":"DP Wang","year":"2020","unstructured":"Wang DP, Kang K, Lin Q, Hai J (2020) Prognostic significance of preoperative systemic cellular inflammatory markers in gliomas: a systematic review and meta-analysis. Clin Transl Sci 13(1):179\u2013188. https:\/\/doi.org\/10.1111\/cts.12700","journal-title":"Clin Transl Sci"},{"issue":"5","key":"1112_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jso.23270","volume":"107","author":"CL Liu","year":"2013","unstructured":"Liu CL, Lee JJ, Liu TP, Chang YC, Hsu YC, Cheng SP (2013) Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol 107(5):493\u2013497. https:\/\/doi.org\/10.1002\/jso.23270","journal-title":"J Surg Oncol"},{"issue":"3","key":"1112_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1515\/enr-2017-0013","volume":"51","author":"S Ozmen","year":"2017","unstructured":"Ozmen S, Timur O, Calik I, Altinkaynak K, Simsek E, Gozcu H, Arslan A, Carlioglu A (2017) Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer. Endocr Regul 51(3):131\u2013136. https:\/\/doi.org\/10.1515\/enr-2017-0013","journal-title":"Endocr Regul"},{"issue":"4","key":"1112_CR23","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3892\/ol.2017.5716","volume":"13","author":"G Luo","year":"2017","unstructured":"Luo G, Liu C, Cheng H, Jin K, Guo M, Lu Y, Long J, Xu J, Ni Q, Chen J, Yu X (2017) Neutrophil-lymphocyte ratio predicts survival in pancreatic neuroendocrine tumors. Oncol Lett 13(4):2454\u20132458. https:\/\/doi.org\/10.3892\/ol.2017.5716","journal-title":"Oncol Lett"},{"key":"1112_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jss.2018.06.058","volume":"232","author":"SM McDermott","year":"2018","unstructured":"McDermott SM, Saunders ND, Schneider EB, Strosberg D, Onesti J, Dillhoff M, Schmidt CR, Shirley LA (2018) Neutrophil lymphocyte ratio and transarterial chemoembolization in neuroendocrine tumor metastases. J Surg Res 232:369\u2013375. https:\/\/doi.org\/10.1016\/j.jss.2018.06.058","journal-title":"J Surg Res"},{"issue":"11","key":"1112_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s11748-017-0804-y","volume":"65","author":"M Okui","year":"2017","unstructured":"Okui M, Yamamichi T, Asakawa A, Harada M, Saito M, Horio H (2017) Prognostic significance of neutrophil-lymphocyte ratios in large cell neuroendocrine carcinoma. Gen Thorac Cardiovasc Surg 65(11):633\u2013639. https:\/\/doi.org\/10.1007\/s11748-017-0804-y","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"6","key":"1112_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000445045","volume":"61","author":"T Salman","year":"2016","unstructured":"Salman T, Kazaz SN, Varol U, Oflazoglu U, Unek IT, Kucukzeybek Y, Alacacioglu A, Atag E, Semiz HS, Cengiz H, Oztop I, Tarhan MO (2016) Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for patients with neuroendocrine tumors: an Izmir Oncology Group Study. Chemotherapy 61(6):281\u2013286. https:\/\/doi.org\/10.1159\/000445045","journal-title":"Chemotherapy"},{"issue":"37","key":"1112_CR27","doi-asserted-by":"publisher","first-page":"e12375","DOI":"10.1097\/MD.0000000000012375","volume":"97","author":"J Zhang","year":"2018","unstructured":"Zhang J, He M, Liu Z, Song Y, Wang Y, Liang R, Chen H, Xu J (2018) Impact of neutrophil-lymphocyte ratio on long-term outcome in patients with craniopharyngioma. Medicine (Baltimore) 97(37):e12375. https:\/\/doi.org\/10.1097\/MD.0000000000012375","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1112_CR28","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610\u2013617 (discussion 617\u2013618)","journal-title":"Neurosurgery"},{"issue":"11","key":"1112_CR29","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, Samuels MH (2016) Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101(11):3888\u20133921. https:\/\/doi.org\/10.1210\/jc.2016-2118","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1112_CR30","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine S (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933\u20133951. https:\/\/doi.org\/10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1112_CR31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P, Klibanski A, Casanueva FF, Wass JAH, Strasburger CJ, Luger A, Clemmons DR, Giustina A (2018) A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14(9):552\u2013561. https:\/\/doi.org\/10.1038\/s41574-018-0058-5","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1112_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65(2):265\u2013273. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02562.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1112_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA, Endocrine S (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1112_CR34","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, Tabarin A, Endocrine S (2015) Treatment of Cushing\u2019s Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 100(8):2807\u20132831. https:\/\/doi.org\/10.1210\/jc.2015-1818","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1112_CR35","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1210\/jc.2003-030751","volume":"88","author":"AM Pereira","year":"2003","unstructured":"Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, Roelfsema F, Romijn JA (2003) Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing\u2019s disease. J Clin Endocrinol Metab 88(12):5858\u20135864. https:\/\/doi.org\/10.1210\/jc.2003-030751","journal-title":"J Clin Endocrinol Metab"},{"issue":"48","key":"1112_CR36","doi-asserted-by":"publisher","first-page":"84506","DOI":"10.18632\/oncotarget.21108","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Su S, Guo Y (2017) The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis. Oncotarget 8(48):84506\u201384514. https:\/\/doi.org\/10.18632\/oncotarget.21108","journal-title":"Oncotarget"},{"issue":"2","key":"1112_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1040-8428(98)00005-5","volume":"28","author":"S Tsagarakis","year":"1998","unstructured":"Tsagarakis S, Kontogeorgos G, Kovacs K (1998) The role of cytokines in the normal and neoplastic pituitary. Crit Rev Oncol Hematol 28(2):73\u201390","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"1112_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1530\/EJE-13-0824","volume":"170","author":"AG Ambrogio","year":"2014","unstructured":"Ambrogio AG, De Martin M, Ascoli P, Cavagnini F, Pecori Giraldi F (2014) Gender-dependent changes in haematological parameters in patients with Cushing\u2019s disease before and after remission. Eur J Endocrinol 170(3):393\u2013400. https:\/\/doi.org\/10.1530\/EJE-13-0824","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1112_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11102-013-0522-0","volume":"17","author":"H Masri-Iraqi","year":"2014","unstructured":"Masri-Iraqi H, Robenshtok E, Tzvetov G, Manistersky Y, Shimon I (2014) Elevated white blood cell counts in Cushing\u2019s disease: association with hypercortisolism. Pituitary 17(5):436\u2013440. https:\/\/doi.org\/10.1007\/s11102-013-0522-0","journal-title":"Pituitary"},{"issue":"3","key":"1112_CR40","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1530\/EJE-15-0308","volume":"173","author":"AM Isidori","year":"2015","unstructured":"Isidori AM, Minnetti M, Sbardella E, Graziadio C, Grossman AB (2015) Mechanisms in endocrinology: The spectrum of haemostatic abnormalities in glucocorticoid excess and defect. Eur J Endocrinol 173(3):R101-113. https:\/\/doi.org\/10.1530\/EJE-15-0308","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"1112_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000314349","volume":"92","author":"L Trementino","year":"2010","unstructured":"Trementino L, Arnaldi G, Appolloni G, Daidone V, Scaroni C, Casonato A, Boscaro M (2010) Coagulopathy in Cushing\u2019s syndrome. Neuroendocrinology 92(Suppl 1):55\u201359. https:\/\/doi.org\/10.1159\/000314349","journal-title":"Neuroendocrinology"},{"issue":"8","key":"1112_CR42","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1210\/jc.2009-0290","volume":"94","author":"B Van Zaane","year":"2009","unstructured":"Van Zaane B, Nur E, Squizzato A, Dekkers OM, Twickler MT, Fliers E, Gerdes VE, Buller HR, Brandjes DP (2009) Hypercoagulable state in Cushing\u2019s syndrome: a systematic review. J Clin Endocrinol Metab 94(8):2743\u20132750. https:\/\/doi.org\/10.1210\/jc.2009-0290","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1112_CR43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1620\/tjem.142.195","volume":"142","author":"T Sato","year":"1984","unstructured":"Sato T, Hiramatsu R, Iwaoka T, Fujii Y, Shimada T, Umeda T (1984) Changes of platelets, serum lactic dehydrogenase, gamma-glutamyltranspeptidase, choline esterase and creatine phosphokinase levels in patients with Cushing\u2019s syndrome. Tohoku J Exp Med 142(2):195\u2013200. https:\/\/doi.org\/10.1620\/tjem.142.195","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"1112_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/bf03345709","volume":"32","author":"C Erem","year":"2009","unstructured":"Erem C, Nuhoglu I, Yilmaz M, Kocak M, Demirel A, Ucuncu O, Onder Ersoz H (2009) Blood coagulation and fibrinolysis in patients with Cushing\u2019s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest 32(2):169\u2013174. https:\/\/doi.org\/10.1007\/bf03345709","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1112_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF03343697","volume":"23","author":"LM Fatti","year":"2000","unstructured":"Fatti LM, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci PM (2000) Markers of activation of coagulation and fibrinolysis in patients with Cushing\u2019s syndrome. J Endocrinol Invest 23(3):145\u2013150. https:\/\/doi.org\/10.1007\/BF03343697","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"1112_CR46","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cen.12524","volume":"82","author":"I Karamouzis","year":"2015","unstructured":"Karamouzis I, Berardelli R, D\u2019Angelo V, Fussotto B, Zichi C, Giordano R, Settanni F, Maccario M, Ghigo E, Arvat E (2015) Enhanced oxidative stress and platelet activation in patients with Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 82(4):517\u2013524. https:\/\/doi.org\/10.1111\/cen.12524","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1112_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/00001721-199212000-00013","volume":"3","author":"GM Patrassi","year":"1992","unstructured":"Patrassi GM, Sartori MT, Viero ML, Scarano L, Boscaro M, Girolami A (1992) The fibrinolytic potential in patients with Cushing\u2019s disease: a clue to their hypercoagulable state. Blood Coagul Fibrinolysis 3(6):789\u2013793. https:\/\/doi.org\/10.1097\/00001721-199212000-00013","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1112_CR48","doi-asserted-by":"publisher","first-page":"2912763","DOI":"10.1155\/2017\/2912763","volume":"2017","author":"G Aranda","year":"2017","unstructured":"Aranda G, Lopez C, Fernandez-Ruiz R, Esteban Y, Garcia-Eguren G, Mora M, Halperin I, Casals G, Ensenat J, Hanzu FA (2017) Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers. Int J Endocrinol 2017:2912763. https:\/\/doi.org\/10.1155\/2017\/2912763","journal-title":"Int J Endocrinol"},{"issue":"3","key":"1112_CR49","doi-asserted-by":"publisher","first-page":"e0120185","DOI":"10.1371\/journal.pone.0120185","volume":"10","author":"A Aulinas","year":"2015","unstructured":"Aulinas A, Ramirez MJ, Barahona MJ, Valassi E, Resmini E, Mato E, Santos A, Crespo I, Bell O, Surralles J, Webb SM (2015) Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing\u2019s syndrome. PLoS ONE 10(3):e0120185. https:\/\/doi.org\/10.1371\/journal.pone.0120185","journal-title":"PLoS ONE"},{"issue":"14","key":"1112_CR50","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1182\/blood-2013-09-525402","volume":"123","author":"Y Xu","year":"2014","unstructured":"Xu Y, Wang S, Shen M, Zhang Z, Chen S, Chen F, Chen M, Zeng D, Wang A, Zhao J, Cheng T, Su Y, Wang J (2014) hGH promotes megakaryocyte differentiation and exerts a complementary effect with c-Mpl ligands on thrombopoiesis. Blood 123(14):2250\u20132260. https:\/\/doi.org\/10.1182\/blood-2013-09-525402","journal-title":"Blood"},{"issue":"6","key":"1112_CR51","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/eje.0.1330635","volume":"133","author":"CJ Auernhammer","year":"1995","unstructured":"Auernhammer CJ, Strasburger CJ (1995) Effects of growth hormone and insulin-like growth factor I on the immune system. Eur J Endocrinol 133(6):635\u2013645. https:\/\/doi.org\/10.1530\/eje.0.1330635","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1112_CR52","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1515\/jpem.1998.11.6.677","volume":"11","author":"S Merchav","year":"1998","unstructured":"Merchav S (1998) The haematopoietic effects of growth hormone and insulin-like growth factor-I. J Pediatr Endocrinol Metab 11(6):677\u2013685. https:\/\/doi.org\/10.1515\/jpem.1998.11.6.677","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"5\u20136","key":"1112_CR53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3109\/10428190009059263","volume":"38","author":"LA Welniak","year":"2000","unstructured":"Welniak LA, Tian ZG, Sun R, Keller JR, Richards S, Ruscetti FW, Murphy WJ (2000) Effects of growth hormone and prolactin on hematopoiesis. Leuk Lymphoma 38(5\u20136):435\u2013445. https:\/\/doi.org\/10.3109\/10428190009059263","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"1112_CR54","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1191\/096120301717164930","volume":"10","author":"LA Welniak","year":"2001","unstructured":"Welniak LA, Richards SM, Murphy WJ (2001) Effects of prolactin on hematopoiesis. Lupus 10(10):700\u2013705. https:\/\/doi.org\/10.1191\/096120301717164930","journal-title":"Lupus"},{"issue":"23","key":"1112_CR55","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","volume":"16","author":"ND Horseman","year":"1997","unstructured":"Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K (1997) Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16(23):6926\u20136935. https:\/\/doi.org\/10.1093\/emboj\/16.23.6926","journal-title":"EMBO J"},{"issue":"4","key":"1112_CR56","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1590\/2359-3997000000054","volume":"60","author":"AA Tam","year":"2016","unstructured":"Tam AA, Kaya C, Baser H, Ersoy R, Cakir B (2016) Mean platelet volume in patients with prolactinoma. Arch Endocrinol Metab 60(4):319\u2013322. https:\/\/doi.org\/10.1590\/2359-3997000000054","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"1112_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","volume":"33","author":"DG Menter","year":"2014","unstructured":"Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV (2014) Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev 33(1):231\u2013269. https:\/\/doi.org\/10.1007\/s10555-014-9498-0","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"1112_CR58","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1042\/BST20180159","volume":"46","author":"A Contursi","year":"2018","unstructured":"Contursi A, Grande R, Dovizio M, Bruno A, Fullone R, Patrignani P (2018) Platelets in cancer development and diagnosis. Biochem Soc Trans 46(6):1517\u20131527. https:\/\/doi.org\/10.1042\/BST20180159","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"1112_CR59","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/1076029612452114","volume":"19","author":"A Girolami","year":"2013","unstructured":"Girolami A, de Marinis GB, Bonamigo E, Treleani M, Vettore S (2013) Arterial and venous thromboses in patients with idiopathic (immunological) thrombocytopenia: a possible contributing role of cortisone-induced hypercoagulable state. Clin Appl Thromb Hemost 19(6):613\u2013618. https:\/\/doi.org\/10.1177\/1076029612452114","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"1112_CR60","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2012.09.009","volume":"225","author":"Y Arbel","year":"2012","unstructured":"Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, Shevach A, Berliner S, Herz I, Keren G, Banai S (2012) Neutrophil\/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis 225(2):456\u2013460. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.09.009","journal-title":"Atherosclerosis"},{"issue":"5","key":"1112_CR61","first-page":"653","volume":"17","author":"S Gokhan","year":"2013","unstructured":"Gokhan S, Ozhasenekler A, Mansur Durgun H, Akil E, Ustundag M, Orak M (2013) Neutrophil lymphocyte ratios in stroke subtypes and transient ischemic attack. Eur Rev Med Pharmacol Sci 17(5):653\u2013657","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"1112_CR62","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1210\/er.2015-1042","volume":"36","author":"C Briet","year":"2015","unstructured":"Briet C, Salenave S, Bonneville JF, Laws ER, Chanson P (2015) Pituitary Apoplexy. Endocr Rev 36(6):622\u2013645. https:\/\/doi.org\/10.1210\/er.2015-1042","journal-title":"Endocr Rev"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01112-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-020-01112-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-020-01112-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T05:10:10Z","timestamp":1620882610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-020-01112-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1112"],"URL":"https:\/\/doi.org\/10.1007\/s11102-020-01112-5","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"12 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by our institutional ethical board (G19.011).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}